March 01, 2007
Woodcock named to new position at FDA
Janet Woodcock was named to a newly created position as FDA chief medical officer in a management reshuffle that brings in John Dyer to hold her previous titles.
The government agency released its latest guidance this week.
11 questions for the GW CEO on the watershed moment.
The Office of Prescription Drug Promotion has sent its second warning letter of the year.